Interleukin-6 serum level and monocyte production in head and neck cancer
- 1 March 1992
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 65 (3) , 479-480
- https://doi.org/10.1038/bjc.1992.97
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Biological and clinical aspects of interleukin 6Immunology Today, 1990
- Detection by in situ hybridization and phenotypic characterization of cells expressing IL-6 mRNA in human stimulated blood.The Journal of Immunology, 1990
- INTERLEUKIN-6 IMMUNOREACTIVITY IN HUMAN-TUMORS1989
- In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice.The Journal of Immunology, 1989
- IL-6 is an intermediate in IL-1-induced thymocyte proliferation.The Journal of Immunology, 1989
- IL-6/IFN-BETA-2 AS A CIRCULATING HORMONE - INDUCTION BY CYTOKINE ADMINISTRATION IN HUMANS1989
- Interleukin 6, the third mediator of acute‐phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 β and tumor necrosis factor‐αEuropean Journal of Immunology, 1988
- B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes.The Journal of Immunology, 1988
- Human β 2 Interferon and B-Cell Differentiation Factor BSF-2 Are IdenticalScience, 1987
- Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production.Proceedings of the National Academy of Sciences, 1987